Page last updated: 2024-09-04

febuxostat and inosine

febuxostat has been researched along with inosine in 5 studies

Compound Research Comparison

Studies
(febuxostat)
Trials
(febuxostat)
Recent Studies (post-2010)
(febuxostat)
Studies
(inosine)
Trials
(inosine)
Recent Studies (post-2010) (inosine)
8181337103,722120740

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Higashino, K; Hiroishi, K; Moriwaki, Y; Nasako, Y; Takahashi, S; Yamakita, J; Yamamoto, T1
Fujimura, Y; Hada, T; Higashino, K; Moriwaki, Y; Takahashi, S; Tsutsui, T; Tsutsumi, Z; Yamamoto, T1
Kamatani, N; Kushiyama, A; Toyo-Oka, L; Toyo-Oka, T1
Hattori, T; Ito, T; Johnson, TA; Kamatani, N; Kamitsuji, S; Koike, Y; Kume, A; Misu, K; Sobue, G; Watanabe, H1
Huang, X; Li, ZL; Ma, KL; Tang, DH; Wang, CY; Ye, YS; Yi, HK; Zhang, JW1

Trials

1 trial(s) available for febuxostat and inosine

ArticleYear
Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine.
    Medicine, 2020, Aug-28, Volume: 99, Issue:35

    Topics: Adenosine Triphosphate; Administration, Oral; Aged; Case-Control Studies; Drug Therapy, Combination; Febuxostat; Female; Gout Suppressants; Humans; Hypoxanthine; Inosine; Japan; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Safety; Treatment Outcome; Xanthine Dehydrogenase

2020

Other Studies

4 other study(ies) available for febuxostat and inosine

ArticleYear
Determination of plasma purine nucleoside phosphorylase activity by high-performance liquid chromatography.
    Analytical biochemistry, 1995, May-01, Volume: 227, Issue:1

    Topics: Adult; Aged; Asthma; Calibration; Chromatography, High Pressure Liquid; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hypoxanthine; Hypoxanthines; Inosine; Male; Middle Aged; Purine-Nucleoside Phosphorylase; Thiazoles; Uric Acid; Xanthine Oxidase

1995
Effect of TEI-6720, a xanthine oxidase inhibitor, on the nucleoside transport in the lung cancer cell line A549.
    Pharmacology, 2000, Volume: 60, Issue:1

    Topics: Allopurinol; Biological Transport; Carrier Proteins; Drug Interactions; Enzyme Inhibitors; Febuxostat; Humans; Hypoxanthine; Inosine; Lung Neoplasms; Membrane Proteins; Nucleoside Transport Proteins; Nucleosides; Pentosyltransferases; Purines; Pyrimidine Phosphorylases; Thiazoles; Tumor Cells, Cultured; Uracil; Uridine; Xanthine; Xanthine Oxidase

2000
Treatment of two mitochondrial disease patients with a combination of febuxostat and inosine that enhances cellular ATP.
    Journal of human genetics, 2019, Volume: 64, Issue:4

    Topics: Adenosine Triphosphate; Aged, 80 and over; Cardiomyopathies; Diabetes Mellitus; Febuxostat; Female; Humans; Hypoxanthine; Inosine; Male; Middle Aged; Mitochondria; Mitochondrial Diseases; Natriuretic Peptide, Brain; Reactive Oxygen Species

2019
Inosine induces acute hyperuricaemia in rhesus monkey (
    Pharmaceutical biology, 2021, Volume: 59, Issue:1

    Topics: Acute Disease; Allopurinol; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Febuxostat; Hyperuricemia; Imino Furanoses; Inosine; Macaca mulatta; Male; Pyrimidinones; Reproducibility of Results; Uric Acid

2021